forty-four adult patients under 60 years of age with acute nonlymphoblastic leukemia were randomized for induction treatment with one of the following three regimens : r 1 = courses of daunorubicin on day 1 + ara-c on days 1 -- 5 ;
C0023467
acute nonlymphoblastic
C0011015
daunorubicin